![[Adobe Stock]](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_750,h_375/https://www.psypost.org/wp-content/uploads/2025/09/brain-1-750x375.jpg)
2025 has been a year of remarkable discovery in the fields of psychology and neuroscience, captivating readers with findings that challenge long-held assumptions about the human mind and body. From the hidden influence of gut bacteria on social anxiety to the surprising linguistic agility of older adults, researchers have uncovered complex connections that shape our daily lives.
The following collection details the 11 most popular articles featured on PsyPost this past year, highlighting the stories that resonated most with the public and offering new insights into mental health, cognitive longevity, and the biological underpinnings of behavior.
A Dormant Virus May Wake Up to Cause Alzheimer’s
A dormant virus residing in nerve cells may eventually contribute to the development of Alzheimer’s disease. Research indicates that the herpes simplex virus type 1, responsible for cold sores, can reactivate later in life and damage brain cells. This process appears to be particularly harmful in individuals carrying the APOE4 gene, a known genetic risk factor for dementia. The study suggests that as the immune system weakens with age, the virus wakes up and triggers inflammation and the accumulation of toxic proteins. These findings propose that antiviral treatments or vaccines could potentially offer a new avenue for preventing neurodegeneration.
Everyday Medications Leave a Cognitive Footprint
Common prescription and over-the-counter medications appear to leave a distinct mark on cognitive function across the population. An analysis of over half a million individuals identified a cognitive footprint associated with various drugs, revealing that some, such as certain antidepressants and epilepsy treatments, are linked to slight reductions in processing speed and memory. In contrast, non-steroidal anti-inflammatory drugs and glucosamine showed a positive association with cognitive performance. While the effects are small on an individual level, the widespread use of these medications implies they could have a cumulative impact on public health.
Insomnia Drug Shows Promise Against Alzheimer’s Damage
A medication typically used to treat insomnia has demonstrated the ability to reduce brain damage associated with Alzheimer’s disease in mice. The drug, lemborexant, works by blocking specific receptors in the brain that regulate wakefulness, promoting deeper sleep. This restoration of sleep rhythms appeared to lower the buildup of tau protein and decrease inflammation within the brain. The results suggest that targeting the sleep-wake system could serve as a viable strategy to slow the progression of neurodegenerative conditions, although further research is needed to confirm these effects in humans.
Rewriting Negative Memories During Sleep
Scientists have developed a method to reduce the emotional intensity of negative memories during sleep. By using audio cues to reactivate positive memories while participants slept, researchers were able to interfere with the consolidation of negative associations formed earlier. This technique, known as targeted memory reactivation, not only weakened the recall of unpleasant events but also increased the involuntary surfacing of positive ones. The study provides evidence that the sleeping brain can be guided to reorganize emotional memories, potentially offering a non-invasive tool for managing conditions like post-traumatic stress disorder.
Social Anxiety Transmitted Through Gut Bacteria
The biological roots of social anxiety may extend beyond the brain to the gut microbiome. When researchers transplanted gut bacteria from socially anxious adolescents into newborn rats, the animals developed increased sensitivity to social fear and exhibited changes in brain chemistry. The study identified specific bacterial imbalances, such as elevated levels of Prevotella, that correlated with these behavioral shifts. This discovery indicates that the gut-brain axis plays a functional role in regulating social behavior and that targeting the microbiome could eventually lead to novel treatments for anxiety disorders.
Brief Stops While Walking Signal Cognitive Risk
Subtle changes in walking patterns may serve as an early warning sign of cognitive decline before standard tests detect any issues. Using smartphone data to track movement during a navigation task, researchers found that older adults at risk for Alzheimer’s frequently paused to reorient themselves. These brief stops distinguished them from cognitively healthy peers and younger adults. The findings imply that everyday navigation behaviors could offer a simple, non-invasive way to screen for early dementia risk, allowing for timelier interventions.
Older Adults Adapt to New Language Trends Surprisingly Fast
A large-scale analysis of historical speeches challenges the idea that language evolution is driven solely by younger generations. By feeding millions of congressional speeches into artificial intelligence models, researchers discovered that older adults adopt new word meanings at nearly the same rate as younger speakers. In some instances, older individuals even led the shift in linguistic trends. These results suggest that language change is a communal process where people of all ages continuously update their vocabulary, countering the stereotype that older adults remain linguistically static.
Morning Coffee Habits Linked to Longer Life
The time of day one consumes coffee may influence its potential health benefits. An analysis of dietary habits linked morning coffee consumption to a lower risk of mortality, particularly from heart disease, compared to non-drinkers or those who drank coffee throughout the day. The protective effect did not appear for individuals who consumed coffee in the afternoon or evening, possibly because late caffeine intake disrupts circadian rhythms and sleep. This research indicates that maximizing the health advantages of coffee might depend on aligning consumption with the body’s natural biological clock.
Blood Pressure Medication May Alleviate ADHD Symptoms
A medication commonly prescribed for high blood pressure has shown potential as a treatment for attention-deficit/hyperactivity disorder. In experiments with zebrafish and rats, amlodipine effectively reduced hyperactivity and impulsivity, mirroring the effects of standard stimulant medications but without the same side effect profile. Genetic analyses further supported a link between the calcium channels targeted by the drug and ADHD symptoms in humans. This repurposing of an existing, well-tolerated drug could provide a new therapeutic option for those who do not respond well to current stimulants.
Calorie-Free Sweeteners May Trick the Brain into Hunger
Calorie-free sweeteners might trick the brain into a state of increased hunger. A study using brain imaging found that consuming sucralose triggered greater activity in the hypothalamus, a region that regulates appetite, compared to sugar or water. This reaction suggests that the sweet taste of sucralose, unaccompanied by the calories the body expects, may disrupt natural satiety signals and heighten the motivation to eat. The effect was particularly pronounced in women and individuals with obesity, indicating that non-caloric sweeteners could inadvertently influence food-seeking behavior.
Genetics Determine How Caffeine Affects Brainpower
Genetic differences appear to dictate how caffeine affects mental performance. Researchers found that individuals who metabolize caffeine quickly performed worse on emotion recognition tasks when they consumed high amounts of the stimulant. In contrast, these same fast metabolizers showed improved executive function with moderate caffeine intake. The study highlights that the cognitive impact of caffeine is not uniform and depends on a complex interaction between an individual’s genetic makeup and their daily consumption habits.
